BioStatus
Generated by Meeveem AI
"Pioneers in novel fluorescent reagents for cell analysis, imaging and cytometry research"
Shepshed
•1 - 10 Employees
•Diagnostics
About BioStatus
BioStatus invents, develops and manufactures novel reagents for cell analysis used in research laboratories, pharmaceutical companies and hospitals worldwide. The company is a pioneer in far-red fluorescent DNA dyes, with products like DRAQ5 and DRAQ7 enabling researchers to visualise cell health, identify dead cells and measure cellular features in flow cytometry, microscopy and high content screening. Founded in 2000, BioStatus manufactures all products in the UK to ISO 9001:2015 standards. The company has grown organically, creating three pharmaceutical spin out companies. BioStatus won the Royal Society of Chemistry's 2012 Teamwork in Innovation Award and is valued for in depth technical support and quality products.
7
Team Members
2000
Founded
Diagnostics
Sector
On-Site
Work Environment
Our Vision
A world where researchers have access to innovative tools that unlock deeper understanding of cell biology, accelerating breakthroughs in drug discovery and healthcare diagnostics.
Our Mission
Invents, develops and markets novel reagents for cell-based research, drug screening and healthcare diagnostics.